The Role of Ultrasound as a Diagnostic Tool for Sarcopenia

被引：84
作者：
Stringer H.J. [1 ]
Wilson D. [1 ,2 ]
机构：
[1] College of Medical and Dental Sciences, University of Birmingham, Edgbaston
[2] Heart of England NHS Foundation Trust, Birmingham
来源：
The Journal of Frailty & Aging | 2018年 / 7卷 / 4期
基金：
英国医学研究理事会;
关键词：
diagnosis; Sarcopenia; ultrasound;
D O I：
10.14283/jfa.2018.24
中图分类号：
学科分类号：
摘要：
Sarcopenia is the progressive loss of skeletal mass and strength, particularly in older adults, with consequent reduction in function and independence. Changing population demographics, have resulted in increased prevalence of sarcopenia and this is associated with a considerable economic burden. Whilst simple, effective, non-intrusive management of this condition exists, no routine diagnosis takes place either in the UK or in many other countries, partly due to an absence of pragmatic clinical diagnostic tools to support the early identification of the syndrome. This position paper aims to provide a short overview proposing the potential case for developing ultrasound as a new and alternative diagnostic tool for identifying sarcopenia. © 2018, The Author(s).
引用
收藏
页码：258 / 261
页数：3
相关论文
共 41 条
  • [1] Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Et al., Sarcopenia: European consensus on definition and diagnosis, Age Ageing., 39, pp. 412-423, (2010)
  • [2] Fielding R.A., Vellas B., Evans W., Et al., Sarcopenia: an undiagnosed condition in older adults.Consensus Definition: Prevalence, Etiology, and Consequences, J Am Med Dir Assoc., 12, pp. 249-256, (2011)
  • [3] Cruz-Jentoft A.J., Landi F., Schneider S.M., Et al., Prevalence of and interventions for sarcopenia in ageing adults: A systematic review, Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing., 43, pp. 48-759, (2014)
  • [4] Patel H.P., Syddall H.E., Jameson K., Et al., Prevalence of sarcopenia in communitydwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: Findings from the Hertfordshire Cohort Study (HCS), Age Ageing., 42, pp. 378-384, (2013)
  • [5] Brown J.C., Harhay M.O., Harhay M.N., Sarcopenia and mortality among a populationbased sample of community–dwelling older adults. J. Cachexia, Sarcopenia Muscle, (2016)
  • [6] Shafiee G., Keshtkar A., Soltani A., Ahadi Z., Larijani B., Heshmat R., Prevalence of sarcopenia in the world: a systematic review and meta–analysis of general population studies, J. Diabetes Metab. Disord. [Internet]. Journal of Diabetes & Metabolic Disorders, 16, (2017)
  • [7] Janssen I., Shepard D.S., Katzmarzyk P.T., Roubenoff R., The healthcare costs of sarcopenia in the United S.. [J Am Geriatr Soc. 2004]–PubMed result, J. Am. Geriatr. Soc. [Internet]., 52, pp. 80-85, (2004)
  • [8] Beaudart C., McCloskey E., Bruyere O., Et al., Sarcopenia in daily practice: assessment and management, BMC Geriatr. [Internet]. BMC Geriatrics, 16, (2016)
  • [9] Burton L.A., Sumukadas D., Optimal management of sarcopenia, Clin. Interv. Aging., 5, pp. 217-228, (2010)
  • [10] Morley J.E., Sarcopenia: Diagnosis and treatment, J. Nutr. Heal. Aging., 12, pp. 452-456, (2008)
12345